nodes	percent_of_prediction	percent_of_DWPC	metapath
Dipivefrin—BCHE—diaphragm—amyotrophic lateral sclerosis	0.099	0.29	CbGeAlD
Dipivefrin—ADRA2A—peripheral nervous system—amyotrophic lateral sclerosis	0.0271	0.0796	CbGeAlD
Dipivefrin—ADRA1A—hindbrain—amyotrophic lateral sclerosis	0.0208	0.0611	CbGeAlD
Dipivefrin—ACHE—medulla oblongata—amyotrophic lateral sclerosis	0.0151	0.0442	CbGeAlD
Dipivefrin—ACHE—spinal cord—amyotrophic lateral sclerosis	0.0134	0.0394	CbGeAlD
Dipivefrin—ADRA1A—brainstem—amyotrophic lateral sclerosis	0.0119	0.035	CbGeAlD
Dipivefrin—ACHE—cerebellum—amyotrophic lateral sclerosis	0.0106	0.0312	CbGeAlD
Dipivefrin—BCHE—brainstem—amyotrophic lateral sclerosis	0.0106	0.0311	CbGeAlD
Dipivefrin—ACHE—brain—amyotrophic lateral sclerosis	0.00865	0.0254	CbGeAlD
Dipivefrin—ADRA2C—medulla oblongata—amyotrophic lateral sclerosis	0.00793	0.0233	CbGeAlD
Dipivefrin—BCHE—medulla oblongata—amyotrophic lateral sclerosis	0.0074	0.0217	CbGeAlD
Dipivefrin—ADRA2C—spinal cord—amyotrophic lateral sclerosis	0.00707	0.0207	CbGeAlD
Dipivefrin—BCHE—spinal cord—amyotrophic lateral sclerosis	0.0066	0.0194	CbGeAlD
Dipivefrin—ADRA2A—medulla oblongata—amyotrophic lateral sclerosis	0.00633	0.0186	CbGeAlD
Dipivefrin—ADRA1A—nervous system—amyotrophic lateral sclerosis	0.00625	0.0183	CbGeAlD
Dipivefrin—ADRA1A—central nervous system—amyotrophic lateral sclerosis	0.00602	0.0177	CbGeAlD
Dipivefrin—ADRA2C—nervous system—amyotrophic lateral sclerosis	0.00596	0.0175	CbGeAlD
Dipivefrin—ADRA1A—cerebellum—amyotrophic lateral sclerosis	0.00589	0.0173	CbGeAlD
Dipivefrin—ADRA2C—central nervous system—amyotrophic lateral sclerosis	0.00574	0.0168	CbGeAlD
Dipivefrin—ADRA2A—spinal cord—amyotrophic lateral sclerosis	0.00564	0.0166	CbGeAlD
Dipivefrin—ADRA2C—cerebellum—amyotrophic lateral sclerosis	0.00561	0.0165	CbGeAlD
Dipivefrin—BCHE—nervous system—amyotrophic lateral sclerosis	0.00556	0.0163	CbGeAlD
Dipivefrin—BCHE—central nervous system—amyotrophic lateral sclerosis	0.00535	0.0157	CbGeAlD
Dipivefrin—BCHE—cerebellum—amyotrophic lateral sclerosis	0.00523	0.0153	CbGeAlD
Dipivefrin—ADRA1A—brain—amyotrophic lateral sclerosis	0.00478	0.014	CbGeAlD
Dipivefrin—ADRA2A—nervous system—amyotrophic lateral sclerosis	0.00476	0.0139	CbGeAlD
Dipivefrin—ADRA2A—central nervous system—amyotrophic lateral sclerosis	0.00458	0.0134	CbGeAlD
Dipivefrin—ADRA2C—brain—amyotrophic lateral sclerosis	0.00456	0.0134	CbGeAlD
Dipivefrin—ADRA2A—cerebellum—amyotrophic lateral sclerosis	0.00448	0.0131	CbGeAlD
Dipivefrin—BCHE—brain—amyotrophic lateral sclerosis	0.00425	0.0125	CbGeAlD
Dipivefrin—ADRA2A—brain—amyotrophic lateral sclerosis	0.00364	0.0107	CbGeAlD
Dipivefrin—ADRA2C—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.0019	0.00288	CbGpPWpGaD
Dipivefrin—ACHE—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.00188	0.00286	CbGpPWpGaD
Dipivefrin—ACHE—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.0018	0.00273	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.00179	0.00271	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism of proteins—EXOSC9—amyotrophic lateral sclerosis	0.00176	0.00267	CbGpPWpGaD
Dipivefrin—ADRA2B—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	0.00175	0.00266	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism of proteins—TUBA4A—amyotrophic lateral sclerosis	0.00166	0.00252	CbGpPWpGaD
Dipivefrin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.00166	0.00252	CbGpPWpGaD
Dipivefrin—ADRA2C—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	0.00164	0.00248	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00163	0.00247	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00163	0.00247	CbGpPWpGaD
Dipivefrin—ADRA2B—Hemostasis—RAB5A—amyotrophic lateral sclerosis	0.00163	0.00247	CbGpPWpGaD
Dipivefrin—ADRA2B—Hemostasis—PFN1—amyotrophic lateral sclerosis	0.00158	0.00239	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.00155	0.00235	CbGpPWpGaD
Dipivefrin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.00154	0.00234	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.00153	0.00232	CbGpPWpGaD
Dipivefrin—ADRA2C—Hemostasis—RAB5A—amyotrophic lateral sclerosis	0.00152	0.00231	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.00152	0.0023	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00149	0.00226	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism of proteins—TUBA4A—amyotrophic lateral sclerosis	0.00148	0.00225	CbGpPWpGaD
Dipivefrin—ADRA2B—Platelet activation, signaling and aggregation—SOD1—amyotrophic lateral sclerosis	0.00148	0.00224	CbGpPWpGaD
Dipivefrin—ADRA2C—Hemostasis—PFN1—amyotrophic lateral sclerosis	0.00147	0.00223	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00145	0.0022	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00145	0.0022	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.00145	0.00219	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism of proteins—DCTN1—amyotrophic lateral sclerosis	0.00141	0.00214	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00139	0.0021	CbGpPWpGaD
Dipivefrin—ADRA2C—Platelet activation, signaling and aggregation—SOD1—amyotrophic lateral sclerosis	0.00138	0.0021	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.00135	0.00206	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00133	0.00202	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	0.00133	0.00202	CbGpPWpGaD
Dipivefrin—ADRA2B—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	0.00133	0.00201	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—FIG4—amyotrophic lateral sclerosis	0.0013	0.00198	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.00126	0.00192	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00126	0.00192	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00126	0.00192	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism of proteins—DCTN1—amyotrophic lateral sclerosis	0.00126	0.00191	CbGpPWpGaD
Dipivefrin—ADRA2C—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	0.00124	0.00188	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00124	0.00187	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—RAB5A—amyotrophic lateral sclerosis	0.00124	0.00187	CbGpPWpGaD
Dipivefrin—ACHE—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.00122	0.00185	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—PFN1—amyotrophic lateral sclerosis	0.0012	0.00181	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—DAO—amyotrophic lateral sclerosis	0.00118	0.00179	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.00117	0.00178	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00116	0.00176	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00115	0.00175	CbGpPWpGaD
Dipivefrin—ADRA2A—Platelet activation, signaling and aggregation—SOD1—amyotrophic lateral sclerosis	0.00112	0.0017	CbGpPWpGaD
Dipivefrin—ADRA2B—G alpha (i) signalling events—C3—amyotrophic lateral sclerosis	0.00112	0.00169	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00107	0.00163	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—DAO—amyotrophic lateral sclerosis	0.00105	0.00159	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	0.00104	0.00158	CbGpPWpGaD
Dipivefrin—ADRA2C—G alpha (i) signalling events—C3—amyotrophic lateral sclerosis	0.00104	0.00158	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00103	0.00156	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00103	0.00156	CbGpPWpGaD
Dipivefrin—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.00101	0.00154	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00101	0.00153	CbGpPWpGaD
Dipivefrin—ADRA2A—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	0.00101	0.00153	CbGpPWpGaD
Dipivefrin—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.00094	0.00143	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000938	0.00142	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	0.00093	0.00141	CbGpPWpGaD
Dipivefrin—ADRA1A—AMPK Signaling—TP53—amyotrophic lateral sclerosis	0.000922	0.0014	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—DAO—amyotrophic lateral sclerosis	0.000913	0.00138	CbGpPWpGaD
Dipivefrin—ADRA2B—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	0.000902	0.00137	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000893	0.00135	CbGpPWpGaD
Dipivefrin—ADRA2B—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000887	0.00135	CbGpPWpGaD
Dipivefrin—ADRB2—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000876	0.00133	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000875	0.00133	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000872	0.00132	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000864	0.00131	CbGpPWpGaD
Dipivefrin—ADRA2A—G alpha (i) signalling events—C3—amyotrophic lateral sclerosis	0.000847	0.00128	CbGpPWpGaD
Dipivefrin—ADRA2C—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	0.000842	0.00128	CbGpPWpGaD
Dipivefrin—ADRA2C—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000829	0.00126	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—GSR—amyotrophic lateral sclerosis	0.000824	0.00125	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00082	0.00124	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000817	0.00124	CbGpPWpGaD
Dipivefrin—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000798	0.00121	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000796	0.00121	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000794	0.00121	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000784	0.00119	CbGpPWpGaD
Dipivefrin—ADRA2B—Hemostasis—SOD1—amyotrophic lateral sclerosis	0.000762	0.00116	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.00075	0.00114	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000742	0.00113	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—DAO—amyotrophic lateral sclerosis	0.000741	0.00112	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—GSR—amyotrophic lateral sclerosis	0.000735	0.00111	CbGpPWpGaD
Dipivefrin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000724	0.0011	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000714	0.00108	CbGpPWpGaD
Dipivefrin—ADRA2C—Hemostasis—SOD1—amyotrophic lateral sclerosis	0.000712	0.00108	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000692	0.00105	CbGpPWpGaD
Dipivefrin—ADRA2A—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	0.000684	0.00104	CbGpPWpGaD
Dipivefrin—ADRA2B—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	0.000684	0.00104	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000676	0.00103	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000676	0.00103	CbGpPWpGaD
Dipivefrin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000673	0.00102	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000669	0.00102	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000667	0.00101	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000664	0.00101	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000649	0.000984	CbGpPWpGaD
Dipivefrin—ADRA2C—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	0.000639	0.000969	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—GSR—amyotrophic lateral sclerosis	0.000638	0.000969	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000631	0.000958	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000619	0.000939	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000617	0.000936	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000611	0.000927	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000603	0.000916	CbGpPWpGaD
Dipivefrin—ACHE—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000603	0.000915	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000603	0.000914	CbGpPWpGaD
Dipivefrin—ADRA2B—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	0.000589	0.000894	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000582	0.000883	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000578	0.000878	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—SOD1—amyotrophic lateral sclerosis	0.000578	0.000877	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000575	0.000872	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000562	0.000852	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000552	0.000837	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000552	0.000837	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000551	0.000835	CbGpPWpGaD
Dipivefrin—ADRA2C—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	0.00055	0.000835	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000545	0.000827	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000544	0.000825	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000534	0.000811	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000528	0.000801	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000524	0.000795	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	0.000519	0.000787	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—GSR—amyotrophic lateral sclerosis	0.000518	0.000787	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000516	0.000782	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000513	0.000778	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000506	0.000767	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000499	0.000758	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000475	0.000721	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000475	0.00072	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.00047	0.000713	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000469	0.000712	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000469	0.000711	CbGpPWpGaD
Dipivefrin—ADRA2B—Hemostasis—IGF1—amyotrophic lateral sclerosis	0.000465	0.000705	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000463	0.000703	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000451	0.000684	CbGpPWpGaD
Dipivefrin—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	0.000447	0.000678	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000443	0.000673	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000442	0.00067	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	0.000441	0.000669	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000438	0.000665	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000436	0.000662	CbGpPWpGaD
Dipivefrin—ADRA2C—Hemostasis—IGF1—amyotrophic lateral sclerosis	0.000434	0.000659	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000426	0.000646	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000423	0.000642	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000419	0.000635	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000406	0.000615	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	0.000393	0.000596	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000392	0.000595	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000388	0.000588	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000387	0.000588	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000383	0.000581	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000382	0.000579	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000377	0.000572	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000377	0.000572	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000366	0.000556	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000364	0.000552	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.00036	0.000546	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000357	0.000541	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000356	0.00054	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—IGF1—amyotrophic lateral sclerosis	0.000353	0.000535	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000347	0.000526	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000342	0.000519	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000334	0.000507	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000324	0.000492	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000324	0.000491	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000322	0.000489	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.00032	0.000486	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000318	0.000483	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000312	0.000473	CbGpPWpGaD
Dipivefrin—ADRA2B—Hemostasis—VEGFA—amyotrophic lateral sclerosis	0.000304	0.000461	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000302	0.000459	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000301	0.000457	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000299	0.000453	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000298	0.000452	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000298	0.000452	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.00029	0.00044	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000288	0.000437	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000284	0.000431	CbGpPWpGaD
Dipivefrin—ADRA2C—Hemostasis—VEGFA—amyotrophic lateral sclerosis	0.000284	0.00043	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000283	0.00043	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000282	0.000429	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000282	0.000427	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—APOE—amyotrophic lateral sclerosis	0.000275	0.000417	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000269	0.000408	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000263	0.000399	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000263	0.000399	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000259	0.000393	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000247	0.000375	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000246	0.000374	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—APOE—amyotrophic lateral sclerosis	0.000245	0.000372	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000245	0.000371	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000243	0.000369	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000235	0.000357	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000232	0.000352	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—VEGFA—amyotrophic lateral sclerosis	0.00023	0.000349	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.00023	0.000349	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000229	0.000348	CbGpPWpGaD
Dipivefrin—ADRA2B—Hemostasis—TP53—amyotrophic lateral sclerosis	0.000229	0.000348	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000229	0.000347	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000229	0.000347	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000219	0.000332	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000216	0.000328	CbGpPWpGaD
Dipivefrin—ADRA2C—Hemostasis—TP53—amyotrophic lateral sclerosis	0.000214	0.000325	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—APOE—amyotrophic lateral sclerosis	0.000213	0.000323	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.00021	0.000319	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000205	0.000311	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000202	0.000307	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000201	0.000305	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000191	0.00029	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000191	0.000289	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000189	0.000287	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000188	0.000286	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000188	0.000286	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000187	0.000284	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000178	0.00027	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000176	0.000267	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—TP53—amyotrophic lateral sclerosis	0.000174	0.000264	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—APOE—amyotrophic lateral sclerosis	0.000173	0.000263	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000168	0.000255	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000167	0.000254	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000158	0.000239	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000156	0.000236	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000156	0.000236	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000155	0.000236	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000147	0.000223	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000146	0.000221	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000145	0.00022	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000129	0.000195	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	0.000121	0.000184	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	0.00012	0.000182	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.00012	0.000181	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000119	0.00018	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	0.000115	0.000174	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	0.000113	0.000172	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	0.000113	0.000172	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	0.000107	0.000162	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	0.000103	0.000156	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	0.000102	0.000154	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	9.9e-05	0.00015	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	9.61e-05	0.000146	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	9.36e-05	0.000142	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	9.2e-05	0.00014	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	8.7e-05	0.000132	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	8.4e-05	0.000128	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	7.81e-05	0.000118	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	7.78e-05	0.000118	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	7.68e-05	0.000116	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—TP53—amyotrophic lateral sclerosis	7.26e-05	0.00011	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	6.35e-05	9.63e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.9e-05	8.95e-05	CbGpPWpGaD
